Search clinical trials for: AlloStim

Total 18 results

Immunovative Therapies, Ltd.
Mirror Biologics, Inc.

Recruiting

Immunotherapy for Advanced Liver Cancer (ALIVE)

Hepatocellular Carcinoma

Thailand, Malaysia
Immunovative Therapies, Ltd.
Mirror Biologics, Inc.

Recruiting

Immunotherapy for Third Line Metastatic Colorectal Cancer (STIMVAX)

Metastatic Colorectal Cancer

United States
Immunovative Therapies, Ltd.
Mirror Biologics, Inc.

Completed

Universal Anti-Viral Vaccine for Healthy Elderly Adults (ALLOPRIME)

Virus Diseases | Pneumonia | Influenza, Human | COVID-19 Respiratory Infection | ARDS, Human | RSV Pneumonia

United States
Galderma R&D

Completed

Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma

Melasma

United States
Immunovative Therapies, Ltd.

Completed

Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck (HNC)

Squamous Cell Carcinoma of the Head and Neck | Cancer of Head and Neck

Thailand
Immunovative Therapies, Ltd.

Completed

AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer

Colorectal Cancer Metastatic

United States
Immunovative Therapies, Ltd.
Hadassah Medical Organization

Completed

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

Lymphoma | Leukemia | Multiple Myeloma | Hematological Malignancy

Israel
Immunovative Therapies, Ltd.

Completed

An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects

Advanced Adult Hepatocellular Carcinoma

Thailand
Immunovative Therapies, Ltd.

Terminated

Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers

Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma

United States
Immunovative Therapies, Ltd.

Withdrawn

In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer

Hepatocellular Carcinoma

Israel
Immunovative Therapies, Ltd.

Withdrawn

Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck

Squamous Cell Carcinoma Head and Neck

Thailand
Michael Har-Noy
Hadassah Medical Organization

Completed

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

Melanoma | Sarcoma | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Non-small Cell Lung Cancer | Solid Tumors Stage II, Stage III and Stage IV

Israel
Immunovative Therapies, Ltd.

Withdrawn

An Individualized Anti-Cancer Vaccine Study in Patients With HCC

Hepatocellular Carcinoma

Israel
Immunovative Therapies, Ltd.

Withdrawn

Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients (MBC)

Metastatic Breast Cancer

United States
Immunovative Therapies, Ltd.

Withdrawn

AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Thailand
The Cleveland Clinic

Terminated

The Effect of Fenoldopam in Solitary Partial Nephrectomy Surgery

Partial Nephrectomy

United States
Bambino Gesù Hospital and Research Institute

Completed

Fenoldopam in Pediatric Cardiac Surgery

Kidney Failure, Acute

Italy
Immunovative Therapies, Ltd.

Completed

In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation

Metastatic Cancer

United States

Search clinical trials for: AlloStim

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations